Table 1 Clinical characteristics of the patients
Patients’ details | No. | Percentage (%) |
|---|---|---|
Sex | ||
Male | 73 | 88 |
Female | 10 | 12 |
Age (year) | ||
< 60 | 55 | 66.3 |
≥ 60 | 28 | 33.7 |
History of chronic illness | ||
Hypertension | 13 | 15.7 |
Diabetes | 10 | 12 |
Coronary artery disease | 3 | 3.6 |
Without chronic disease | 57 | 68.7 |
Liver cirrhosis | ||
Yes | 58 | 69.9 |
No | 25 | 30.1 |
No. of HCC foci | ||
1 | 44 | 53 |
≥ 2 | 39 | 47 |
Maximum diameter range of HCC foci (cm) | ||
<5 | 74 | 89.2 |
≥ 5 | 9 | 10.8 |
Treatment modalities of HCC | ||
Resection only | 10 | 12 |
TACE only | 12 | 14.5 |
Comprehensive treatment | 61 | 73.5 |
AFP levels when oligometastases were diagnosed (ng/mL) | ||
≥ 500 | 35 | 42.2 |
< 500 | 50 | 60.2 |
Extents of oligometastases | ||
Unilateral Pulmonary | 82 | 55.8 |
Bilateral Pulmonary | 65 | 44.2 |
Maximum diameter range of lesions (mm) | ||
Unilateral Pulmonary | 4–27 |  |
Bilateral Pulmonary | 7–42 |  |
No. of lesion ablation | 116 | Â |
1 | 58 | 50 |
2 | 20 | 34.5 |
3 | 6 | 15.5 |